Haley Gittleman

29.1k total citations · 9 hit papers
77 papers, 21.1k citations indexed

About

Haley Gittleman is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Haley Gittleman has authored 77 papers receiving a total of 21.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Genetics, 38 papers in Pulmonary and Respiratory Medicine and 21 papers in Epidemiology. Recurrent topics in Haley Gittleman's work include Glioma Diagnosis and Treatment (40 papers), Brain Metastases and Treatment (22 papers) and Meningioma and schwannoma management (12 papers). Haley Gittleman is often cited by papers focused on Glioma Diagnosis and Treatment (40 papers), Brain Metastases and Treatment (22 papers) and Meningioma and schwannoma management (12 papers). Haley Gittleman collaborates with scholars based in United States, Taiwan and Israel. Haley Gittleman's co-authors include Jill S. Barnholtz‐Sloan, Quinn T. Ostrom, Carol Kruchko, Yingli Wolinsky, P Farah, Yaning Chen, Courtney Kromer, Alexander L. Boscia, Gino Cioffi and Kristin Waite and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Haley Gittleman

74 papers receiving 20.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010

2013 9.9k citations Quinn T. Ostrom, Haley Gittleman et al. Neuro-Oncology profile →
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016

2019 1.7k citations Quinn T. Ostrom, Gino Cioffi et al. Neuro-Oncology profile →
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

2015 1.6k citations Quinn T. Ostrom, Haley Gittleman et al. Neuro-Oncology profile →
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015

2018 1.5k citations Quinn T. Ostrom, Haley Gittleman et al. Neuro-Oncology profile →
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011

2014 1.3k citations Quinn T. Ostrom, Haley Gittleman et al. Neuro-Oncology profile →
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014

2017 1.2k citations Quinn T. Ostrom, Haley Gittleman et al. Neuro-Oncology profile →
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009–2013

2016 871 citations Quinn T. Ostrom, Haley Gittleman et al. Neuro-Oncology profile →
Epidemiology of Gliomas

2014 310 citations Quinn T. Ostrom, Haley Gittleman et al. Cancer treatment and research profile →
FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer

2022 127 citations Jaleh Fallah, Sundeep Agrawal et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Haley Gittleman

Since Specialization

Citations

This map shows the geographic impact of Haley Gittleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haley Gittleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haley Gittleman more than expected).

Fields of papers citing papers by Haley Gittleman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haley Gittleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haley Gittleman. The network helps show where Haley Gittleman may publish in the future.

Co-authorship network of co-authors of Haley Gittleman

This figure shows the co-authorship network connecting the top 25 collaborators of Haley Gittleman. A scholar is included among the top collaborators of Haley Gittleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haley Gittleman. Haley Gittleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Food and Drug Administration pooled analysis of overall survival according to depth of response in frontline advanced immune-oncology renal cell carcinoma trials 2025 ·JNCI Cancer Spectrum ·Elaine Chang, Haley Gittleman, (unknown), Erik Bloomquist, (unknown), Chana Weinstock, Sundeep Agrawal, Nicole Gormley, Shenghui Tang, Daniel L. Suzman, Laleh Amiri‐Kordestani, Richard Pazdur, Paul G. Kluetz, David H. McDermott, Meredith M. Regan, Brian I. Rini	0
2	A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma 2024 ·Clinical Cancer Research ·Elaine Chang, (unknown), Chi Song, Haley Gittleman, Laura L. Fernandes, Chana Weinstock, Michael B. Atkins, Sundeep Agrawal, (unknown), Nicole Gormley, Shenghui Tang, Daniel L. Suzman, Laleh Amiri‐Kordestani, Paul G. Kluetz, Richard Pazdur, Brian I. Rini, David F. McDermott, Meredith M. Regan	5
3	FDA pooled analysis of overall survival according to depth of response as a continuous variable in frontline advanced immuno-oncology renal cell carcinoma trials. 2023 ·Journal of Clinical Oncology ·Elaine Chang, Haley Gittleman, (unknown), Erik Bloomquist, Chana Weinstock, Sundeep Agrawal, Rajeshwari Sridhara, Nicole Gormley, Laleh Amiri‐Kordestani, Shenghui Tang, Paul G. Kluetz, Daniel L. Suzman, Richard Pazdur, David F. McDermott, Meredith M. Regan, Brian I. Rini	0
4	FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer breakdown → 2022 ·Clinical Cancer Research ·Jaleh Fallah, Sundeep Agrawal, Haley Gittleman, Mallorie H. Fiero, Sriram Subramaniam, Christy S. John, (unknown), Tiffany K. Ricks, Gang Niu, Anthony F. Fotenos, (unknown), Kelly Chiang, William F. Pierce, Daniel L. Suzman, Shenghui Tang, Richard Pazdur, Laleh Amiri‐Kordestani, Amna Ibrahim, Paul G. Kluetz	127
5	Impact of race on care, readmissions, and survival for patients with glioblastoma: an analysis of the National Cancer Database 2021 ·Neuro-Oncology Advances ·Tiffany R. Hodges, Collin M. Labak, Uma V. Mahajan, Christina Huang Wright, James Wright, Gino Cioffi, Haley Gittleman, (unknown), Xiaofei Zhou, Kelsey Duncan, Carol Kruchko, Andrew E. Sloan, Jill S. Barnholtz‐Sloan	17
6	Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores – A pooled analysis of RTOG 0129 and 0522 2021 ·Oral Oncology ·Musaddiq Awan, Haley Gittleman, Jill S. Barnholtz‐Sloan, Mitchell Machtay, Phuc Félix Nguyen‐Tan, David I. Rosenthal, Christopher J. Schultz, (unknown), Wade L. Thorstad, Steven J. Frank, Harold Kim, Robert L. Foote, Miriam N. Lango, George Shenouda, Mohan Suntharalingam, Jonathan Harris, Qiang Zhang, Quynh‐Thu Le, Min Yao	6
7	Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT 2019 ·Journal of Neuro-Oncology ·(unknown), Haley Gittleman, (unknown), Quinn T. Ostrom, Carol Kruchko, Terri S. Armstrong, Mark R. Gilbert, Jill S. Barnholtz‐Sloan	14
8	Factors Influencing Patients’ Intention to Perform Physical Activity During Hematopoietic Cell Transplantation 2019 ·Oncology nursing forum ·(unknown), (unknown), (unknown), Mary K. Anthony, Haley Gittleman, Paolo F. Caimi, Susan R. Mazanec	2
9	Perceived Needs, Preparedness, and Emotional Distress of Male Caregivers of Postsurgical Women With Gynecologic Cancer 2018 ·Oncology nursing forum ·Susan R. Mazanec, (unknown), Haley Gittleman, Barbara J. Daly	34
10	The ratio of HLA-DR and VNN2+ expression on CD14+ myeloid derived suppressor cells can distinguish glioblastoma from radiation necrosis patients 2017 ·Journal of Neuro-Oncology ·David Soler, A. B. Young, Kevin D. Cooper, Amber Kerstetter-Fogle, Jill S. Barnholtz‐Sloan, Haley Gittleman, Thomas S. McCormick, Andrew E. Sloan	19
11	CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014 breakdown → 2017 ·Neuro-Oncology ·Quinn T. Ostrom, Haley Gittleman, Peter Liao, (unknown), Yingli Wolinsky, Carol Kruchko, Jill S. Barnholtz‐Sloan	1246
12	Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation 2017 ·Journal of Neuro-Oncology ·Jason K. Molitoris, Yuan James Rao, (unknown), Liam Kane, Shahed N. Badiyan, Haley Gittleman, Jill S. Barnholtz‐Sloan, Søren M. Bentzen, Tim J. Kruser, Jiayi Huang, Minesh P. Mehta	17
13	Validation of an automated tractography method for the optic radiations as a biomarker of visual acuity in neurofibromatosis-associated optic pathway glioma 2017 ·Experimental Neurology ·Peter de Blank, Michael J. Fisher, Haley Gittleman, Jill S. Barnholtz‐Sloan, Chaitra Badve, Jeffrey Berman	12
14	Racial disparities in melanoma survival 2016 ·Journal of the American Academy of Dermatology ·Sean M. Dawes, (unknown), Haley Gittleman, Jill S. Barnholtz‐Sloan, Jeremy S. Bordeaux	127
15	Laser interstitial thermal therapy followed by minimal-access transsulcal resection for the treatment of large and difficult to access brain tumors 2016 ·Neurosurgical FOCUS ·James Wright, (unknown), Christina Huang Wright, Fernando Alonso, Alia Hdeib, Haley Gittleman, Jill S. Barnholtz‐Sloan, Andrew E. Sloan	47
16	An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825 2016 ·Neuro-Oncology ·Haley Gittleman, (unknown), Michael W. Kattan, Arnab Chakravarti, Mark R. Gilbert, Andrew B. Lassman, Simon S. Lo, Mitchell Machtay, Andrew E. Sloan, Erik P. Sulman, (unknown), Michael A. Vogelbaum, Tony J. C. Wang, Marta Peñas-Prado, Emad Youssef, Deborah T. Blumenthal, Peixin Zhang, Minesh P. Mehta, Jill S. Barnholtz‐Sloan	131
17	A Cross-sectional Study of KLKB1 and PRCP Polymorphisms in Patient Samples with Cardiovascular Disease 2016 ·Frontiers in Medicine ·Haley Gittleman, Alona Merkulova, Omar Alhalabi, Evi X. Stavrou, Martina Veigl, Jill S. Barnholtz‐Sloan, Alvin H. Schmaier	16
18	Comparative Brain and Central Nervous System Tumor Incidence and Survival between the United States and Taiwan Based on Population-Based Registry 2016 ·Frontiers in Public Health ·Li‐Nien Chien, Haley Gittleman, Quinn T. Ostrom, Kuo‐Sheng Hung, Andrew E. Sloan, Yi‐Chen Hsieh, Carol Kruchko, Lisa R. Rogers, (unknown), Hung‐Yi Chiou, Jill S. Barnholtz‐Sloan	47
19	CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012 breakdown → 2015 ·Neuro-Oncology ·Quinn T. Ostrom, Haley Gittleman, Jordonna Fulop, (unknown), (unknown), Courtney Kromer, Yingli Wolinsky, Carol Kruchko, Jill S. Barnholtz‐Sloan	1599
20	Epidemiology of Gliomas breakdown → 2014 ·Cancer treatment and research ·Quinn T. Ostrom, Haley Gittleman, Lindsay Stetson, Selene Virk, Jill S. Barnholtz‐Sloan	310

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact